207 related articles for article (PubMed ID: 7653484)
1. Increased plasma serotonin in primary pulmonary hypertension.
Hervé P; Launay JM; Scrobohaci ML; Brenot F; Simonneau G; Petitpretz P; Poubeau P; Cerrina J; Duroux P; Drouet L
Am J Med; 1995 Sep; 99(3):249-54. PubMed ID: 7653484
[TBL] [Abstract][Full Text] [Related]
2. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
[TBL] [Abstract][Full Text] [Related]
3. Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension.
Ulrich S; Huber LC; Fischler M; Treder U; Maggiorini M; Eberli FR; Speich R
Respiration; 2011; 81(3):211-6. PubMed ID: 20431284
[TBL] [Abstract][Full Text] [Related]
4. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.
Weir EK; Reeve HL; Johnson G; Michelakis ED; Nelson DP; Archer SL
Chest; 1998 Sep; 114(3 Suppl):200S-204S. PubMed ID: 9741569
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Humbert M; Labrune P; Sitbon O; Le Gall C; Callebert J; Hervé P; Samuel D; Machado R; Trembath R; Drouet L; Launay JM; Simonneau G
Eur Respir J; 2002 Jul; 20(1):59-65. PubMed ID: 12166582
[TBL] [Abstract][Full Text] [Related]
6. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
7. The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.
Kazimierczyk R; Błaszczak P; Kowal K; Jasiewicz M; Knapp M; Szpakowicz A; Ptaszyńska-Kopczyńska K; Sobkowicz B; Waszkiewicz E; Grzywna R; Musial WJ; Kamiński KA
Cytokine; 2018 Jul; 107():52-58. PubMed ID: 29203267
[TBL] [Abstract][Full Text] [Related]
8. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation in experimental murine neonatal pulmonary hypertension.
Davizon-Castillo P; Allawzi A; Sorrells M; Fisher S; Baltrunaite K; Neeves K; Nozik-Grayck E; DiPaola J; Delaney C
Physiol Rep; 2020 Mar; 8(5):e14386. PubMed ID: 32163236
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing platelet serotonin uptake in essential hypertension.
Jafri SM; Chandra N; Dhawan S; Soni D; Chandra M; Shanker K
Int J Cardiol; 1992 Mar; 34(3):327-33. PubMed ID: 1563858
[TBL] [Abstract][Full Text] [Related]
11. Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats.
Kanai Y; Hori S; Tanaka T; Yasuoka M; Watanabe K; Aikawa N; Hosoda Y
Cardiovasc Res; 1993 Sep; 27(9):1619-23. PubMed ID: 8287439
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and pulmonary hypertension in human septic ARDS.
Sibbald W; Peters S; Lindsay RM
Crit Care Med; 1980 Sep; 8(9):490-4. PubMed ID: 7418423
[TBL] [Abstract][Full Text] [Related]
13. Plasma serotonin levels are normal in pulmonary arterial hypertension.
Lederer DJ; Horn EM; Rosenzweig EB; Karmally W; Jahnes M; Barst RJ; Kawut SM
Pulm Pharmacol Ther; 2008; 21(1):112-4. PubMed ID: 17374499
[TBL] [Abstract][Full Text] [Related]
14. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
15. Increased concentrations of serotonin and 5-hydroxyindoleacetic acid in blood plasma from patients with pulmonary hypertension due to mitral valve disease.
Kirillova VV; Nigmatullina RR; Dzhordzhikiya RK; Kudrin VS; Klodt PM
Bull Exp Biol Med; 2009 Apr; 147(4):408-10. PubMed ID: 19704935
[TBL] [Abstract][Full Text] [Related]
16. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
Herve P; Drouet L; Dosquet C; Launay JM; Rain B; Simonneau G; Caen J; Duroux P
Am J Med; 1990 Jul; 89(1):117-20. PubMed ID: 2368783
[No Abstract] [Full Text] [Related]
17. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
18. Serotonin and heart rate in hypertensive and normotensive subjects.
Missouris CG; Cappuccio FP; Varsamis E; Barron JL; Carr E; Markandu ND; MacGregor GA
Am Heart J; 1998 May; 135(5 Pt 1):838-43. PubMed ID: 9588414
[TBL] [Abstract][Full Text] [Related]
19. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
Weiss HJ; Tschopp TB; Rogers J; Brand H
J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
[TBL] [Abstract][Full Text] [Related]
20. Plasma serotonin levels and the platelet serotonin transporter.
Brenner B; Harney JT; Ahmed BA; Jeffus BC; Unal R; Mehta JL; Kilic F
J Neurochem; 2007 Jul; 102(1):206-15. PubMed ID: 17506858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
